News 2020-07-03
The Launching of Official Website for 2020 Pharmaceutical Crystallization Summit
J-Star Research, a wholly owned subsidiary of Porton Pharma Solution Ltd., engages with Xtalpi and a broad selection of industrial and academic leaders to host the 2020 Pharmaceutical Crystallization Summit on October 7th and 8th, 2020 (Live).
We will take a close look at the ever-expanding toolbox of capabilities needed to meet challenges in API crystallization. The Summit will emphasize the importance of understanding fundamentals and root causes of problems to effectively speed up process and product development.
Considering the impact of the Covid-19 outbreak, this year’s Summit will be held online (live). This provides the advantage of allowing more attendees than a normal face-to-face meeting. The registration for invited attendees starts in June, and the registration for the general public starts on August 7th, 2020. Registration Reminder for public audience will be released through Porton official channels in August.
Warmly welcome our customers and investors to follow us on this Summit in the coming months.
Website:
https://crystallization-summit.jstar-research.com/
LinkedIn:
https://www.linkedin.com/company/center-for-pharma-crystallization-cfpc/
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes

News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.